Scancell announces Genmab exercises option to a second commercial license agreement

by alex | Dec 4, 2024 | Latest News, Regulatory News

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Scancell announces further positive data from the ongoing SCOPE trial of SCIB1 with double CPIs for Advanced Melanoma

by chantal | Nov 18, 2024 | Latest News, Regulatory News, SCIB1

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Result of 2024 Annual General Meeting

by admin | Oct 25, 2024 | Latest News, Regulatory News

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Scancell announces strengthening of leadership team as it closes on value-generating inflection points

by admin | Oct 22, 2024 | Latest News, News, Regulatory News

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Notice of AGM

by admin | Oct 1, 2024 | Latest News, Regulatory News

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Scancell Preliminary Results for the Year Ended 30 April 2024

by admin | Sep 24, 2024 | Latest News, Regulatory News

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!